Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients

por Tomita, Yoshihiko, Tatsugami, Katsunori, Nakaigawa, Noboru, Osawa, Takahiro, Oya, Mototsugu, Kanayama, Hiroomi, Nakayama Kondoh, Chihiro, Sassa, Naoto, Nishimura, Kazuo, Nozawa, Masahiro, Masumori, Naoya, Miyoshi, Yasuhide, Kuroda, Shingo, Tanaka, Shingo, Kimura, Akiko, Tamada, Satoshi
Publicado 2020